Loading clinical trials...
Loading clinical trials...
NT-proBNP is a major diagnostic and prognostic marker in cardiology, but it is also a new marker for biological inflammation, especially in rheumatology. Its evaluation in chronic inflammatory bowel ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Centre Hospitalier Universitaire, Amiens
NCT04844606 · Ulcerative Colitis, Ulcerative Colitis Chronic, and more
NCT06553053 · Crohn's Disease Relapse, Inflammatory Bowel Diseases
NCT06226883 · Inflammatory Bowel Diseases, Crohn's Disease
NCT05986136 · Inflammatory Bowel Diseases
NCT06266663 · Inflammatory Bowel Diseases
CHU Amiens Picardie
Amiens, Picardie
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions